Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan Medoxomil + Chlorthalidone in Moderate to Severe Hypertension
NCT00847626Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of azilsartan medoxomil in hypertension (HTN), sponsored by Takeda. Started Jan 2009; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00847626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847626.